免疫肿瘤学进展：非小细胞肺癌中的免疫检查点抑制剂——引言 - Suppr

Suppr

超能文献

Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.

作者信息

Socinski Mark A

机构信息

Co-Leader, UPCI Lung Cancer Program University of Pittsburgh Medical Center Pittsburgh, PA.

出版信息

Semin Oncol. 2015 Oct;42 Suppl 2:S1-2. doi: 10.1053/j.seminoncol.2015.09.018. Epub 2015 Sep 11.

DOI:10.1053/j.seminoncol.2015.09.018

PMID:26477469

Abstract

摘要

相似文献

Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.

Semin Oncol. 2015 Oct;42 Suppl 2:S1-2. doi: 10.1053/j.seminoncol.2015.09.018. Epub 2015 Sep 11.

Understanding the Rationale for Immunotherapy in Non-Small Cell Lung Cancer.

Semin Oncol. 2015 Oct;42 Suppl 2:S3-10. doi: 10.1053/j.seminoncol.2015.09.016. Epub 2015 Sep 11.

Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer.

Semin Oncol. 2015 Oct;42 Suppl 2:S11-8. doi: 10.1053/j.seminoncol.2015.09.019. Epub 2015 Sep 11.

PD-1-targeted immunotherapy: recent clinical findings.

Clin Adv Hematol Oncol. 2012 Oct;10(10):674-5.

The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System.

Ann Am Thorac Soc. 2017 Aug;14(8):1248-1260. doi: 10.1513/AnnalsATS.201702-152FR.

[Immuno-Oncology therapeutic principles in lung and renal cell carcinoma].

Oncol Res Treat. 2014;37 Suppl 4:10-3. doi: 10.1159/000366433. Epub 2014 Sep 30.

[Not Available].

Bull Cancer. 2016 Nov;103 Suppl 1:S138-S143. doi: 10.1016/S0007-4551(16)30371-X.

Nivolumab instills hope in a hopeless situation in advanced nonsmall cell lung cancer with poor performance status.

Indian J Cancer. 2017 Jan-Mar;54(1):55-56. doi: 10.4103/ijc.IJC_10_17.

Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology.

Expert Opin Biol Ther. 2016 Dec;16(12):1479-1489. doi: 10.1080/14712598.2016.1234602. Epub 2016 Sep 21.

Harnessing the immune system for the treatment of non-small-cell lung cancer.

J Clin Oncol. 2013 Mar 10;31(8):1021-8. doi: 10.1200/JCO.2012.45.8703. Epub 2013 Feb 11.

引用本文的文献

Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors.

Neuro Oncol. 2020 Nov 26;22(11):1658-1666. doi: 10.1093/neuonc/noaa066.

Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases.

BMC Cancer. 2018 Mar 1;18(1):239. doi: 10.1186/s12885-018-4131-1.

Gliomatosis Cerebri: Current Understanding and Controversies.

Front Oncol. 2017 Aug 7;7:165. doi: 10.3389/fonc.2017.00165. eCollection 2017.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.

Semin Oncol. 2015 Oct;42 Suppl 2:S1-2. doi: 10.1053/j.seminoncol.2015.09.018. Epub 2015 Sep 11.

Understanding the Rationale for Immunotherapy in Non-Small Cell Lung Cancer.

Semin Oncol. 2015 Oct;42 Suppl 2:S3-10. doi: 10.1053/j.seminoncol.2015.09.016. Epub 2015 Sep 11.

Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer.

Semin Oncol. 2015 Oct;42 Suppl 2:S11-8. doi: 10.1053/j.seminoncol.2015.09.019. Epub 2015 Sep 11.

PD-1-targeted immunotherapy: recent clinical findings.

Clin Adv Hematol Oncol. 2012 Oct;10(10):674-5.

The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System.

Ann Am Thorac Soc. 2017 Aug;14(8):1248-1260. doi: 10.1513/AnnalsATS.201702-152FR.

[Immuno-Oncology therapeutic principles in lung and renal cell carcinoma].

Oncol Res Treat. 2014;37 Suppl 4:10-3. doi: 10.1159/000366433. Epub 2014 Sep 30.

[Not Available].

Bull Cancer. 2016 Nov;103 Suppl 1:S138-S143. doi: 10.1016/S0007-4551(16)30371-X.

Nivolumab instills hope in a hopeless situation in advanced nonsmall cell lung cancer with poor performance status.

Indian J Cancer. 2017 Jan-Mar;54(1):55-56. doi: 10.4103/ijc.IJC_10_17.

Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology.

Expert Opin Biol Ther. 2016 Dec;16(12):1479-1489. doi: 10.1080/14712598.2016.1234602. Epub 2016 Sep 21.

Harnessing the immune system for the treatment of non-small-cell lung cancer.

J Clin Oncol. 2013 Mar 10;31(8):1021-8. doi: 10.1200/JCO.2012.45.8703. Epub 2013 Feb 11.

引用本文的文献

Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors.

Neuro Oncol. 2020 Nov 26;22(11):1658-1666. doi: 10.1093/neuonc/noaa066.

Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases.

BMC Cancer. 2018 Mar 1;18(1):239. doi: 10.1186/s12885-018-4131-1.

Gliomatosis Cerebri: Current Understanding and Controversies.

Front Oncol. 2017 Aug 7;7:165. doi: 10.3389/fonc.2017.00165. eCollection 2017.